Preliminary safety and efficacy with sustained objective responses observed in patients with lymphoma treated with MT-601 in Phase 1 APOLLO study MT-601 was well tolerated with no observation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results